Eli Lilly Launches Open Letter about Mounjaro® and Zepbound® Use
Lilly's Open Letter on Tirzepatide Medicines: Mounjaro and Zepbound should not be used for cosmetic weight loss. Patient safety is top priority.
7939 NW 21st St
Miami, Florida
Lilly's Open Letter on Tirzepatide Medicines: Mounjaro and Zepbound should not be used for cosmetic weight loss. Patient safety is top priority.
Low iodine levels linked to higher testosterone in US men. Study suggests excess iodine may be harmful. #Iodine #Testosterone #Health
New diabetes drug Zepbound, also known as tirzepatide, can be sold as a weight-loss drug, helping dieters lose 40-60 pounds.
Miracle weight loss drugs are set to become more available after the US approves Zepbound, a cheaper competitor to Wegovy.